Skip to main content
MedPathMedPath Home
Clinical Trials/NCT05317143
NCT05317143
Completed
N/A

Evaluation of Prostate Cancer Margins

Intuitive Surgical1 site in 1 country100 target enrollmentFebruary 22, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsProstate Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Intuitive Surgical
Enrollment
100
Locations
1
Primary Endpoint
Positive Margin
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Pathological assessment of prostate tissue

Registry
clinicaltrials.gov
Start Date
February 22, 2022
End Date
November 10, 2022
Last Updated
last year
Study Type
Observational
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Diagnosed with prostate cancer
  • •Subject must be scheduled for robotic-assisted radical prostatectomy at the clinical site.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Positive Margin

Time Frame: Immediately postoperatively, expected same day as surgery

Detection of positive margin

Study Sites (1)

Loading locations...

Similar Trials

Active, Not Recruiting
N/A
Diagnostic imaging in prostate cancer (as in tumours with accelerated menbrane turn-over)by F-18 Fluoro-metil-choline PET/CTpatients with prostate cancer istologically provenMedDRA version: 14.1Level: SOCClassification code 10038359Term: Renal and urinary disordersSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 14.1Level: SOCClassification code 10022891Term: InvestigationsSystem Organ Class: 10022891 - InvestigationsTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2008-003337-24-ITCENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA
Completed
Phase 1
Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold KitProstatic Neoplasm
NCT03183544Cliniques universitaires Saint-Luc- Université Catholique de Louvain3
Active, Not Recruiting
N/A
Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate CancerProstate Carcinoma
NCT06326216Mayo Clinic98
Completed
Phase 1
Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal MicroscopyProstate Cancer
NCT06398470University College, London21
Completed
N/A
Novel Imaging in Staging of Primary Prostate CancerHigh Risk Prostate Cancer
NCT03537391Turku University Hospital80